Drug middlemen in the hot seat: Q&A with USC Schaeffer Center’s Erin Trish

Constantly rising prescription drug prices appear to be driven in part by a little-understood group of firms called “pharmacy benefit managers.” USC Schaeffer Center research on the topic has the attention of the FTC and Congress, which has called executives to testify next week.